How to Help Your Patients Find Ganciclovir in Stock: A Provider's Guide

When a patient is discharged or transitions to outpatient care requiring ganciclovir, the prescribing team is often the last line of defense between the patient and a dangerous gap in antiviral therapy. The challenge is real: ganciclovir IV is a specialty injectable that most retail pharmacies don't carry, and the ophthalmic gel (Zirgan) can be hard to find due to its high cost and low stocking rates.

This guide gives providers concrete, actionable strategies to help patients navigate medication access — from choosing the right dispensing channel to leveraging modern search tools that save time and prevent treatment delays.

Step 1: Determine Which Dispensing Channel Is Right for Your Patient

Not every ganciclovir patient uses the same pharmacy channel. Matching the dispensing channel to the patient's clinical situation is the first step in preventing access gaps:

Home infusion pharmacy: For patients receiving IV ganciclovir at home or through an outpatient infusion center. Home infusion pharmacies stock ganciclovir IV as a routine product and can provide supplies along with IV bags, tubing, and nursing coordination. Examples: Optum Infusion, Option Care, BioPlus.

Hospital outpatient pharmacy: Many academic medical centers and transplant hospitals have outpatient pharmacies that can dispense ganciclovir IV directly to patients being managed at that institution. This is often the smoothest handoff for transplant patients.

Retail or specialty pharmacy (for Zirgan): The ophthalmic gel is dispensed through retail pharmacies. Not all locations stock it; pharmacies may need to special-order it within 1-2 business days. Independent pharmacies often have more flexibility.

Step 2: Include Pharmacy Details in the Discharge Plan

Providers can dramatically reduce post-discharge access problems by including pharmacy coordination in the discharge planning process — not just adding it as an afterthought on the discharge summary. Best practices include:

Contacting the home infusion pharmacy or hospital outpatient pharmacy before discharge to confirm supply and start the benefits investigation process

Providing patients with the pharmacy's name, phone number, and the specific prescription details (drug, dose, frequency, duration) in writing at discharge

Sending the prescription electronically to the receiving pharmacy before the patient leaves — not waiting for the patient to deliver a paper prescription

If a transition to oral valganciclovir is planned, send that prescription simultaneously to a retail pharmacy so there is no gap between IV and oral therapy

Step 3: Give Patients a Specific Pharmacy to Call

Generic guidance — "go find a pharmacy" — is often insufficient for immunocompromised patients who are already dealing with serious illness. When possible, give your patient a specific phone number and contact at a pharmacy you know stocks ganciclovir. Your clinic's care coordinator or social worker can maintain a running list of local pharmacies that reliably carry ganciclovir IV and Zirgan.

Step 4: Use medfinder to Locate Pharmacies With Ganciclovir in Stock

For patients who need to find ganciclovir at a retail or specialty pharmacy, medfinder is a paid service that calls pharmacies on the patient's behalf to check which ones have a specific medication in stock. Instead of the patient making dozens of calls — often while still recovering — medfinder does the outreach and texts results back. Providers can recommend medfinder to patients who are trying to fill ganciclovir at a retail or specialty pharmacy.

Step 5: Know the Insurance and Prior Auth Landscape

Ganciclovir IV is typically billed through medical benefits (not pharmacy), since it is administered in a clinical setting. This can create confusion for patients and families expecting a standard pharmacy co-pay. Key points for providers:

Inpatient ganciclovir is covered under the hospital stay billing

Home infusion ganciclovir is billed through the home infusion company, usually under Part B (Medicare) or commercial medical benefits

Prior authorization may be required for home infusion coverage — initiate this process before discharge to avoid a gap in therapy

Zirgan ophthalmic gel is typically covered under pharmacy benefits; a prior authorization form may be needed

Step 6: Address Cost Barriers Proactively

The Zirgan ophthalmic gel has a retail price exceeding $500 per tube. For uninsured or underinsured patients, GoodRx coupons can reduce the cost significantly. For more details on savings options, see our guide on how to save money on ganciclovir.

When to Transition to Valganciclovir

For most clinically stable outpatients, valganciclovir (Valcyte, 900 mg PO) is the practical successor to IV ganciclovir and is far more accessible at retail pharmacies. Transitioning to valganciclovir as soon as it is clinically appropriate — typically after 14-21 days of IV induction for CMV retinitis, or immediately for transplant prophylaxis — simplifies medication logistics for patients and eliminates the need for IV access.